Jessica Hagen

Dave Rosa, president and CEO of NeuroOne, joins MobihealthNews for Part 2 of the Emerging Technologies series to discuss the company's thin-film electrode technology.

Chethan Sarabu, director of clinical innovation for the health tech hub at Cornell Tech, previews his HIMSS26 talk on AI's environmental impact and actions stakeholders can take to reduce it.

The acquisition allows Sword to scale its presence in the U.S. and bring its physical therapy platform to the German market.

The company will use the Series A funding to enhance its API for integration and expand into new clinical practice areas.

In Part 1 of Season 2 of MobiHealthNews’ Emerging Technologies series, Mark Zhang, acting assistant under secretary for health, explains how innovation is scaling across the VA.

The British company, which reached a $2.1 billion valuation just a year ago, allows text to be turned into clinical compliance and training videos using AI avatars.

The situation marked a rare medical emergency that prompted an early return from the ISS, highlighting how crews manage serious health events in space.

Cherry Drulis, director of Samsung's healthcare mobile B2B, teases her upcoming HIMSS26 talk, which will highlight the wearables-focused partnership between Pearson and the tech giant.

Carlsmed's cofounder, president and CEO sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss how the company uses patient imaging and 3D printing to create personalized spine implants for surgery.

AION Labs CEO sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss the acquisition he says represents a milestone for Israel’s biotech ecosystem.